About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Gemcitabine in NK/T Cell Lymphoma

Gemcitabine in NK/T Cell Lymphoma

NCT01660568·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Samsung Medical Center

Age

15–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

NK/T cell lymphoma
relapse or refractory disease
gemcitabine containing treatment

The record

StatusCompleted

PhaseNo phase

Taking part20

StartedAug 2012

UpdatedFeb 13, 2013

Conditions

NK/T Cell Lymphoma

Where1

Samsung Medical Center
Seoul, South Korea